Trends in Metabolic Dysfunction in Polycystic Ovary Syndrome: a Bibliometric Analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Sep 13

PMID 37701893

Authors

Yan Xu

Zhiqun Cao

Ting Chen

Jian Ren

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a very common chronic disease and causes reproductive disorders in women of childbearing age worldwide. The cause of metabolic dysfunction in PCOS is unknown, and there is a lack of systematic bibliometric analysis for this disease. This study included 3,972 articles on metabolic dysfunction in PCOS published from 2012 to 2021. We applied the VOSviewer and the CiteSpace scientometric analysis software to analyze the data regarding the publication of the articles, countries, authors, institutions, scientific categories, cited journals, and keywords. Through this analysis, we determined the research efforts and their developing trends and anticipated the progress in understanding PCOS-related metabolic dysfunction.

Citing Articles

Hotspots and status of Fetal Alpha-Thalassemia from 2009 to 2023: a bibliometric analysis.

Li Q, Li X, He S, Li J Front Pediatr. 2024; 12:1467760.

PMID: 39726529 PMC: 11670076. DOI: 10.3389/fped.2024.1467760.

A bibliometric analysis of domestic and international research on hemorrhagic fever with renal syndrome over the past 2 decades.

Zhou W, Dong Y, Liu X, Ding S, Si H, Yang C Medicine (Baltimore). 2024; 103(37):e39737.

PMID: 39287241 PMC: 11404925. DOI: 10.1097/MD.0000000000039737.

Plant medicine metabolite Yulinzhu treating neurological disorder causing polycystic ovary syndrome: a systematic review and a meta-analysis.

Jiao B, Chen R, Chen S, Zhang J, Wang P, Zhou H Front Pharmacol. 2024; 15:1458621.

PMID: 39211785 PMC: 11357959. DOI: 10.3389/fphar.2024.1458621.

Bibliometric analysis of research in epilepsy and comorbid depression from 2014 to 2023.

Chen L, He X, Li X, Yang J, Huang H World J Psychiatry. 2024; 14(6):985-998.

PMID: 38984335 PMC: 11230101. DOI: 10.5498/wjp.v14.i6.985.

References

Lindheim L, Bashir M, Munzker J, Trummer C, Zachhuber V, Leber B . Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS One. 2017; 12(1):e0168390. PMC: 5207627. DOI: 10.1371/journal.pone.0168390. View

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

Sapmaz-Metin M, Topcu-Tarladacalisir Y, Uz Y, Inan M, Kurt Omurlu I, Cerkezkayabekir A . Vitamin E modulates apoptosis and c-jun N-terminal kinase activation in ovarian torsion-detorsion injury. Exp Mol Pathol. 2013; 95(2):213-9. DOI: 10.1016/j.yexmp.2013.07.007. View

Kempegowda P, Melson E, Manolopoulos K, Arlt W, OReilly M . Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020; 11:2042018820934319. PMC: 7315669. DOI: 10.1177/2042018820934319. View

Badawy A, Elnashar A . Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011; 3:25-35. PMC: 3039006. DOI: 10.2147/IJWH.S11304. View

Turnbaugh P, Backhed F, Fulton L, Gordon J . Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3(4):213-23. PMC: 3687783. DOI: 10.1016/j.chom.2008.02.015. View

Palomba S, Piltonen T, Giudice L . Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2020; 27(3):584-618. DOI: 10.1093/humupd/dmaa051. View

Wan T, Wang Z, Luo Y, Zhang Y, He W, Mei Y . FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling. Oxid Med Cell Longev. 2019; 2019:8239642. PMC: 6914945. DOI: 10.1155/2019/8239642. View

Yang Y, Ouyang N, Ye Y, Hu Q, Du T, Di N . The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome. Reprod Biomed Online. 2020; 41(4):734-742. DOI: 10.1016/j.rbmo.2020.07.013. View

10.

Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y . Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019; 25(8):1225-1233. PMC: 7376369. DOI: 10.1038/s41591-019-0509-0. View

11.

Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y . Association between Polycystic Ovary Syndrome and Gut Microbiota. PLoS One. 2016; 11(4):e0153196. PMC: 4836746. DOI: 10.1371/journal.pone.0153196. View

12.

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

13.

Xue J, Li X, Liu P, Li K, Sha L, Yang X . Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice. Endocr J. 2019; 66(10):859-870. DOI: 10.1507/endocrj.EJ18-0567. View

14.

Chen Z, Zhao H, He L, Shi Y, Qin Y, Shi Y . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2010; 43(1):55-9. DOI: 10.1038/ng.732. View

15.

Norman R, Dewailly D, Legro R, Hickey T . Polycystic ovary syndrome. Lancet. 2007; 370(9588):685-97. DOI: 10.1016/S0140-6736(07)61345-2. View

16.

Huang J, Chen P, Xiang Y, Liang Q, Wu T, Liu J . Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022; 107:108717. DOI: 10.1016/j.intimp.2022.108717. View

17.

Arffman R, Saraswat M, Joenvaara S, Khatun M, Agarwal R, Tohmola T . Thromboinflammatory changes in plasma proteome of pregnant women with PCOS detected by quantitative label-free proteomics. Sci Rep. 2019; 9(1):17578. PMC: 6879536. DOI: 10.1038/s41598-019-54067-4. View

18.

Clarke I, Cummins J, Findlay J, Burman K, Doughton B . Effects on plasma luteinizing hormone and follicle-stimulating hormone of varying the frequency and amplitude of gonadotropin-releasing hormone pulses in ovariectomized ewes with hypothalamo-pituitary disconnection. Neuroendocrinology. 1984; 39(3):214-21. DOI: 10.1159/000123982. View

19.

Gonzalez F, Rote N, Minium J, Kirwan J . Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 91(1):336-40. DOI: 10.1210/jc.2005-1696. View

20.

Dumesic D, Hoyos L, Chazenbalk G, Naik R, Padmanabhan V, Abbott D . Mechanisms of intergenerational transmission of polycystic ovary syndrome. Reproduction. 2019; 159(1):R1-R13. PMC: 6989388. DOI: 10.1530/REP-19-0197. View